Latest Observability News

Integrated Research has reported a softer first half of FY26 with an anticipated EBITDA loss driven by increased credit losses and investments in new products, despite multiple product launches.

The ACCC has given informal clearance for the merger between Southern Cross Media Group and Seven West Media, marking a key regulatory milestone. The deal still awaits shareholder and ACMA approvals before completion.

Waratah Minerals reports significant new gold intercepts at its Spur and Consols Zones, expanding the promising Spur Gold Corridor in NSW. The company also accelerates exploration with more rigs and advanced assay technology.

Iltani Resources has reported compelling assay results from its VTEM-targeted drilling at the Orient Silver-Indium Project, revealing multiple thick zones of high-grade silver-lead-zinc-indium mineralisation. These findings validate VTEM as a powerful exploration tool and hint at a significant expansion of the existing resource.

The Australian Competition and Consumer Commission has given the green light to Southern Cross Media’s proposed acquisition of Seven West Media, marking a significant regulatory milestone in the evolving Australian media landscape.

Torque Metals has reported a significant high-grade gold intercept at its HHH deposit in Western Australia, hitting 5 metres at 15.2 grams per tonne gold. The company is now poised to advance exploration with downhole electromagnetic surveys to identify further mineralisation.

Anteris Technologies has gained FDA approval to start patient recruitment in the US for its pivotal PARADIGM Trial, following initial European regulatory success. The company advances manufacturing and clinical readiness as it pushes toward key regulatory milestones.

Temas Resources has completed 1,000m of a 2,500m diamond drilling program at its La Blache project in Quebec, targeting expansion of titanium and critical minerals resources. Early signs of gallium and scandium add to the project's potential value.

Immutep Limited’s Phase II EFTISARC-NEO trial reveals a novel immunotherapy combo delivering a striking 51.5% tumour response in soft tissue sarcoma patients, alongside robust immune activation signals.

Mount Gibson Iron has announced a further extension of its on-market share buy-back program, now set to run until November 2026, maintaining flexibility amid uncertain market conditions.

Radiopharm Theranostics has successfully enrolled the second cohort in its Phase 1 trial of 177Lu-RAD204, with the Data Safety Monitoring Committee greenlighting a dose increase to 90mCi for the third cohort. Early results show promising tumor targeting and safety in multiple advanced cancers.

Krakatoa Resources reports significant progress in drilling at its Zopkhito Antimony-Gold Project in Georgia, with most holes intersecting visible antimony mineralisation. Assay results are eagerly awaited to validate historical resource estimates and support a maiden JORC-compliant Mineral Resource.